Related Experiment Video
Updated: Dec 25, 2025

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
Published on: September 6, 2024
Commentary: rapamycin for the aging skin
1Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, PA, 19102, USA. cs389@drexel.edu.
Abstract:
A response is provided to a commentary on a recent study examining the impact of low-dose topical application of rapamycin on markers of aging in the skin. The barriers to clinical implementation of therapies targeting the fundamental aging process are discussed, and the topical study is placed in context with the broader effort to develop new therapeutics for age-related disorders.
Insights
Topical rapamycin shows promise for skin aging. Further research is needed to overcome barriers to clinical use for age-related conditions.
Area of Science:
- Dermatology
- Gerontology
- Pharmacology
Background:
- A recent study investigated the effects of low-dose topical rapamycin on skin aging markers.
- This response addresses commentary on that study, discussing its implications.
Discussion:
- Barriers to clinical translation of aging therapies are significant.
- Implementing fundamental aging process interventions faces regulatory and practical hurdles.
- The topical rapamycin study is contextualized within broader anti-aging therapeutic development.
Key Insights:
- Topical rapamycin may offer a localized approach to mitigating skin aging.
- Understanding and overcoming clinical implementation barriers is crucial for advancing aging research.
- This work contributes to the ongoing development of therapeutics for age-related disorders.
Outlook:
- Further investigation into topical rapamycin's efficacy and safety is warranted.
- Addressing barriers to clinical implementation will accelerate the development of anti-aging interventions.
- This research supports the potential for targeted therapies in managing age-related skin conditions.
More Related Videos
10:21Mechanistic Insight into the Development of TNBS-Mediated Intestinal Fibrosis and Evaluating the Inhibitory Effects of Rapamycin
Published on: September 12, 2019
05:28A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction
Published on: August 27, 2019
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Renewal of Skin Epidermal Stem Cells
The Effect of Aging on Tissues
PI3K/mTOR/AKT Signaling Pathway
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Tissue Renewal without Stem Cells
However, failure of such a system...